Flexbumin 200 g/l solution for infusion
Authorisation PA2004/002/001 · Baxalta Innovations GmbH
- Licence holder
- Baxalta Innovations GmbH (all products →)
- Active substance
- Human plasma protein
- Dosage form
- Solution for infusion
- Route of administration
- Intravenous use
- ATC codes
- B05AA, B05AA01
- First authorised
- 24/08/2007
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Human plasma protein: supply and approvals
6 authorised products on the HPRA list contain Human plasma protein. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 19 years (since 24 August 2007). The HPRA list marks it as marketed in Ireland.
Other medicines with Human plasma protein in Ireland
5 other products on the HPRA list contain Human plasma protein, from 3 licence holders; 4 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Hepatect CP 50 IU/ml solution for infusion | Biotest Pharma GmbH | National authorisation (PA) | Marketed |
| Intratect 100 g/L, solution for infusion | Biotest Pharma GmbH | National authorisation (PA) | Marketed |
| LG-octaplas, solution for infusion | Octapharma (IP) | National authorisation (PA) | Marketed |
| Tetagam P, prefilled syringeSolution for injection for intramuscular use | CSL Behring GmbH | National authorisation (PA) | Marketed |
| LG-octaplas, Powder and solvent for solution for infusion | Octapharma (IP) | National authorisation (PA) | Not stated |
Other substances in ATC group B05AA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 14 other active substances share the group B05AA with this product:
Sodium chloride (4) · Potassium chloride (3) · Magnesium chloride hexahydrate (3) · Human plasma protein not containing less than 96% human albumin (2) · Human albumin (2) · Succinylated gelatine (= modified fluid gelatine) (2) · Modified liquid gelatine (2) · Plasma protein containing at least 95% human albumin (2) · Sodium acetate trihydrate (1) · Calcium chloride dihydrate (1) · Sodium hydroxide (1) · Sodium (s)-lactate solution (1) · Sodium lactate solution (1) · Human albumin macro aggregated (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Baxalta Innovations GmbH holds 21 products on the HPRA list, with 14 different active substances; 5 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.